Tempus, Inc. is a technology firm focused on healthcare that is based in Chicago, Illinois. They collect and analyze both clinical and molecular data and analyze genomic sequencing data in their lab taken from cancer seeking treatment. The Tempus platform presents this data to their doctors who use it to make the best decisions about what treatment paths to follow.This company was co-founded by Eric Lefkofsky who also leads it as its CEO. He says that his company is bringing cutting-edge technology to the field of healthcare, something that he saw was distinctly lacking when presented with an up-close view of how cancer was being treated.
His technology is being used to treat one in four cancer patients in the U.S. and could be used in other nations as well in the not so distant future.Eric Lefkosfky collaborates with others to improve the state of healthcare in the United States, forming partnerships with hundreds of hospitals and clinics. In October 2018 he started a collaborative partnership with Mary Crowley Research. Their goal is to develop more research options for people with lung cancer. Mary Crowley Cancer Research will use Tempus as their preferred provider when a molecular sequencing needs to be performed as well as providing clinical support and analysis.
He is one of the most influential entrepreneurs in Chicago. Eric Lefkofsky had co-founded several technology firms there including, Echo Global Logistics, Lighbank, and InnerWorkings. He helps the Chicago community as a business philanthropist by supporting many causes. He is the trustee for Lurie Children’s Hospital as well as World Business Chicago, The Museum of Science and Industry, and the Art Institute of Chicago. He and his wife have also signed the Giving Pledge and so have committed to philanthropically giving half of their wealth to various important causes.